A clinical trial showed that the drug lenacapavir protected 100 percent of women and girls against HIV infection. The drug only needs to be injected twice a year to provide full protection. New results suggest that an annual injection may be sufficient for long-lasting protection.
AIDS-related deaths in India decreased by 79 percent between 2010 and 2023. New HIV infections decreased by 44 percent during the same period, exceeding the global reduction of 39 percent.
PEPFARβs efforts have led to significant decreases in HIV prevalence, especially in Africa.
HIV among pregnant South Africans has decreased to 27.5% in 2022, the lowest since 2002.